Penwest Pharmaceuticals CO.
(MM)
   
To register click here

Penwest Stock Price PPCO

Company Description : The Company develops pharmaceutical products based on innovative proprietary drug delivery technologies with a focus on products that address disorders of the nervous system. url: www.penw.com

Name:
Penwest Pharmaceuticals CO. (MM)
Symbol:
NASDAQ:PPCO
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.041.402.892.244.152.962.812.9610573816:41:34
To register Click hereRegister for free Penwest Pharmaceuticals stock prices.

Penwest Pharmaceutical 1Q loss 41 cents a share; revenue falls to $739,000 : NEW YORK (Thomson Financial) - Penwest Pharmaceuticals Co. Friday reported a first-quarter net loss of $10.3 million, or 41 cents a share, wider than the mean estimate of analysts polled by Thomson Reuters of a loss of...

Free Penwest Stock Charts

Penwest Historical Stock Chart
Penwest Pharmaceuticals Historical Stock Chart
Penwest Monthly Stock Chart
Penwest Pharmaceuticals Monthly Stock Chart
Penwest Intraday stock chart
Penwest Pharmaceuticals Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Penwest Pharmaceuticals stock Price, quotes, trades and FREE Penwest Pharmaceuticals stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Penwest Pharmaceuticals (PPCO) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Penwest News

Latest Penwest News Headlines
DateTimeSource
Headline
05/02/20088:27AMTFNFPenwest Pharmaceutical 1Q loss 41 cents a share; revenue falls to $739,000
03/06/20089:20AMTFNFPenwest Pharmaceuticals to privately sell 8.14 million units
02/20/200811:32AMTFNFMarket Spotlight: Generic Drugs
02/15/20087:27PMTFNFAccipiter Life Sciences nominates three directors to Penwest board
02/15/20086:54PMPRNUSAccipiter Life Sciences Announces Nomination of Three Independent Director Candidates for Election to the Penwest Board at the 2
02/15/20085:19PMTFNFEndo Pharma, Penwest get Paragraph IV notice over Opana
02/04/20089:25AMTFNFPenwest Pharma says study results support further development of Nalbuphine
01/25/20086:28PMTFNFEndo Pharma, Penwest Pharma file patent suit over Impax Labs' generic Opana
01/07/20084:32PMTFNFEndo Pharma sees 2008 per-share profit of $2.10 to $2.15 and net sales growth

Penwest Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Penwest Pharmaceuticals company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Penwest Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  700 2.8771 07/25/2008 4:16PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
32 site:2us nasdaq ppco080725 18:55 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )